Applied Health Economics and Health Policy

Papers
(The H4-Index of Applied Health Economics and Health Policy is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual Framework75
Is the Use of Unanchored Matching-Adjusted Indirect Comparison Always Superior to Naïve Indirect Comparison on Survival Outcomes? A Simulation Study48
Australian Preferences for Prenatal Screening: A Discrete Choice Experiment Comparing Metropolitan and Rural/Regional Areas35
Population Norms for SF-6Dv2 and EQ-5D-5L in China33
Methods and Practical Considerations for Conducting Budget Impact Analysis for Non-Pharmaceutical Interventions31
Developing a Framework for the Health Technology Assessment of Histology-independent Precision Oncology Therapies30
Productivity Losses due to Health Problems Arising from COVID-19 Pandemic: A Systematic Review of Population-Level Studies Worldwide30
Comment on: “Willingness to Pay for a COVID-19 Vaccine”28
Effect of Competition on Generic Drug Prices26
Financial Incentives in the Path to Recovery from the COVID-19 Pandemic26
Does the Choice of Health Metric, DALY or QALY, Influence Conclusions of Health Economic Evaluation? A Case Study of Rotavirus Vaccine in Burundi23
Korean Guidelines for Pharmacoeconomic Evaluations: Updates in the Third Version23
Correction to: Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canaglifozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting22
Using Economics to Impact Local Obesity Policy: Introducing the UK Centre for Economics of Obesity (CEO)20
Economic Evaluations of Preventive Interventions for Dental Caries and Periodontitis: A Systematic Review19
Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis19
Herd Immunity Effects in Cost-Effectiveness Analyses among Low- and Middle-Income Countries17
A Comparative Analysis of Anticancer Drug Appraisals Including Managed Entry Agreements in South Korea and England17
0.06975793838501